We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
Cap. Flow
-$786M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.5M
2
INDA icon
iShares MSCI India ETF
INDA
+$9.67M
3
IBKC
IBERIABANK Corp
IBKC
+$8.93M
4
HYT icon
BlackRock Corporate High Yield Fund
HYT
+$8.03M
5
AMZN icon
Amazon
AMZN
+$7.15M

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$16.7M
2
NFLX icon
Netflix
NFLX
+$15.8M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$15.7M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$15.1M
5
MDCO
Medicines Co
MDCO
+$11.9M

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Consumer Discretionary 3.94%
3 Healthcare 3.91%
4 Communication Services 2.7%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
2301
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-33,635
Closed -$203K
THOR
2302
DELISTED
Synthorx, Inc. Common Stock
THOR
– –
-57,912
Closed -$4.05M
WCG
2303
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-47,481
Closed -$15.7M
WCG
2304
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-1,000
Closed -$330K
ARQL
2305
CALL
DELISTED
Arqule Inc
ARQL
– –
-36,200
Closed -$723K
ARQL
2306
DELISTED
Arqule Inc
ARQL
– –
-242,463
Closed -$4.84M
ARQL
2307
PUT
DELISTED
Arqule Inc
ARQL
– –
-21,200
Closed -$423K
BOLD
2308
CALL
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-1,000
Closed -$60K
BOLD
2309
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-278,465
Closed -$16.7M
BOLD
2310
PUT
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-3,500
Closed -$209K
JAG
2311
DELISTED
Jagged Peak Energy Inc.
JAG
– –
-90,218
Closed -$766K
MDCO
2312
CALL
DELISTED
Medicines Co
MDCO
– –
-4,500
Closed -$382K
MDCO
2313
DELISTED
Medicines Co
MDCO
– –
-139,534
Closed -$11.9M
MDCO
2314
PUT
DELISTED
Medicines Co
MDCO
– –
-10,300
Closed -$875K
AVP
2315
CALL
DELISTED
Avon Products, Inc.
AVP
– –
-100
Closed -$1K
TRCB
2316
DELISTED
Two River Bancorp
TRCB
– –
-10,000
Closed -$224K
ENFC
2317
DELISTED
Entegra Financial Corp.
ENFC
– –
-46,888
Closed -$1.41M
BKJ
2318
DELISTED
Bancorp of New Jersey, Inc.
BKJ
– –
-208
Closed -$4K
CART
2319
DELISTED
Carolina Trust BancShares
CART
– –
-5,087
Closed -$66K
VIAB
2320
CALL
DELISTED
Viacom Inc. Class B
VIAB
– –
-8,200
Closed -$344K
MACK
2321
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-6,699
Closed -$21K
CBPO
2322
DELISTED
China Biologic Products Holdings, Inc.
CBPO
– –
-7,360
Closed -$857K
CDOR
2323
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
– –
-28,890
Closed -$319K
WPG
2324
DELISTED
Washington Prime Group Inc.
WPG
– –
-811
Closed -$19.1K
IO
2325
DELISTED
ION Geophysical Corporation
IO
– –
-9,959
Closed -$86K
91 92
93
94 95

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.

  • Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
  • Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
  • Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
  • Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
  • Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
  • Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
  • Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.